Global Pre-Exposure Prophylaxis Market Insights, Forecast to 2029
This report presents an overview of global market for Pre-Exposure Prophylaxis, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Pre-Exposure Prophylaxis, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pre-Exposure Prophylaxis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pre-Exposure Prophylaxis sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Pre-Exposure Prophylaxis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Pre-Exposure Prophylaxis sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Gilead Sciences, Teva Pharmaceuticals, Strides Pharma Science and Lupin, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pre-Exposure Prophylaxis in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pre-Exposure Prophylaxis manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pre-Exposure Prophylaxis sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
This report researches the key producers of Pre-Exposure Prophylaxis, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pre-Exposure Prophylaxis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pre-Exposure Prophylaxis sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Pre-Exposure Prophylaxis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Pre-Exposure Prophylaxis sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Gilead Sciences, Teva Pharmaceuticals, Strides Pharma Science and Lupin, etc.
By Company
- Gilead Sciences
- Teva Pharmaceuticals
- Strides Pharma Science
- Lupin
- Truvada
- Discovy
- Adult
- Adolescent
- US & Canada
- U.S.
- Canada
- China
- Asia (excluding China)
- Japan
- South Korea
- China Taiwan
- Southeast Asia
- India
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Middle East, Africa, Latin America
- Brazil
- Mexico
- Turkey
- Israel
- GCC Countries
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pre-Exposure Prophylaxis in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pre-Exposure Prophylaxis manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pre-Exposure Prophylaxis sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 STUDY COVERAGE
1.1 Pre-Exposure Prophylaxis Product Introduction
1.2 Market by Type
1.2.1 Global Pre-Exposure Prophylaxis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Truvada
1.2.3 Discovy
1.3 Market by Application
1.3.1 Global Pre-Exposure Prophylaxis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Adult
1.3.3 Adolescent
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Pre-Exposure Prophylaxis Sales Estimates and Forecasts 2018-2029
2.2 Global Pre-Exposure Prophylaxis Revenue by Region
2.2.1 Global Pre-Exposure Prophylaxis Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Pre-Exposure Prophylaxis Revenue by Region (2018-2023)
2.2.3 Global Pre-Exposure Prophylaxis Revenue by Region (2024-2029)
2.2.4 Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2018-2029)
2.3 Global Pre-Exposure Prophylaxis Sales Estimates and Forecasts 2018-2029
2.4 Global Pre-Exposure Prophylaxis Sales by Region
2.4.1 Global Pre-Exposure Prophylaxis Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Pre-Exposure Prophylaxis Sales by Region (2018-2023)
2.4.3 Global Pre-Exposure Prophylaxis Sales by Region (2024-2029)
2.4.4 Global Pre-Exposure Prophylaxis Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Pre-Exposure Prophylaxis Sales by Manufacturers
3.1.1 Global Pre-Exposure Prophylaxis Sales by Manufacturers (2018-2023)
3.1.2 Global Pre-Exposure Prophylaxis Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pre-Exposure Prophylaxis in 2022
3.2 Global Pre-Exposure Prophylaxis Revenue by Manufacturers
3.2.1 Global Pre-Exposure Prophylaxis Revenue by Manufacturers (2018-2023)
3.2.2 Global Pre-Exposure Prophylaxis Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Pre-Exposure Prophylaxis Revenue in 2022
3.3 Global Key Players of Pre-Exposure Prophylaxis, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Pre-Exposure Prophylaxis Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pre-Exposure Prophylaxis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pre-Exposure Prophylaxis, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pre-Exposure Prophylaxis, Product Offered and Application
3.8 Global Key Manufacturers of Pre-Exposure Prophylaxis, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Pre-Exposure Prophylaxis Sales by Type
4.1.1 Global Pre-Exposure Prophylaxis Historical Sales by Type (2018-2023)
4.1.2 Global Pre-Exposure Prophylaxis Forecasted Sales by Type (2024-2029)
4.1.3 Global Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2029)
4.2 Global Pre-Exposure Prophylaxis Revenue by Type
4.2.1 Global Pre-Exposure Prophylaxis Historical Revenue by Type (2018-2023)
4.2.2 Global Pre-Exposure Prophylaxis Forecasted Revenue by Type (2024-2029)
4.2.3 Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2018-2029)
4.3 Global Pre-Exposure Prophylaxis Price by Type
4.3.1 Global Pre-Exposure Prophylaxis Price by Type (2018-2023)
4.3.2 Global Pre-Exposure Prophylaxis Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Pre-Exposure Prophylaxis Sales by Application
5.1.1 Global Pre-Exposure Prophylaxis Historical Sales by Application (2018-2023)
5.1.2 Global Pre-Exposure Prophylaxis Forecasted Sales by Application (2024-2029)
5.1.3 Global Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2029)
5.2 Global Pre-Exposure Prophylaxis Revenue by Application
5.2.1 Global Pre-Exposure Prophylaxis Historical Revenue by Application (2018-2023)
5.2.2 Global Pre-Exposure Prophylaxis Forecasted Revenue by Application (2024-2029)
5.2.3 Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2018-2029)
5.3 Global Pre-Exposure Prophylaxis Price by Application
5.3.1 Global Pre-Exposure Prophylaxis Price by Application (2018-2023)
5.3.2 Global Pre-Exposure Prophylaxis Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Pre-Exposure Prophylaxis Market Size by Type
6.1.1 US & Canada Pre-Exposure Prophylaxis Sales by Type (2018-2029)
6.1.2 US & Canada Pre-Exposure Prophylaxis Revenue by Type (2018-2029)
6.2 US & Canada Pre-Exposure Prophylaxis Market Size by Application
6.2.1 US & Canada Pre-Exposure Prophylaxis Sales by Application (2018-2029)
6.2.2 US & Canada Pre-Exposure Prophylaxis Revenue by Application (2018-2029)
6.3 US & Canada Pre-Exposure Prophylaxis Market Size by Country
6.3.1 US & Canada Pre-Exposure Prophylaxis Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Pre-Exposure Prophylaxis Sales by Country (2018-2029)
6.3.3 US & Canada Pre-Exposure Prophylaxis Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Pre-Exposure Prophylaxis Market Size by Type
7.1.1 Europe Pre-Exposure Prophylaxis Sales by Type (2018-2029)
7.1.2 Europe Pre-Exposure Prophylaxis Revenue by Type (2018-2029)
7.2 Europe Pre-Exposure Prophylaxis Market Size by Application
7.2.1 Europe Pre-Exposure Prophylaxis Sales by Application (2018-2029)
7.2.2 Europe Pre-Exposure Prophylaxis Revenue by Application (2018-2029)
7.3 Europe Pre-Exposure Prophylaxis Market Size by Country
7.3.1 Europe Pre-Exposure Prophylaxis Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Pre-Exposure Prophylaxis Sales by Country (2018-2029)
7.3.3 Europe Pre-Exposure Prophylaxis Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Pre-Exposure Prophylaxis Market Size
8.1.1 China Pre-Exposure Prophylaxis Sales (2018-2029)
8.1.2 China Pre-Exposure Prophylaxis Revenue (2018-2029)
8.2 China Pre-Exposure Prophylaxis Market Size by Application
8.2.1 China Pre-Exposure Prophylaxis Sales by Application (2018-2029)
8.2.2 China Pre-Exposure Prophylaxis Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Pre-Exposure Prophylaxis Market Size by Type
9.1.1 Asia Pre-Exposure Prophylaxis Sales by Type (2018-2029)
9.1.2 Asia Pre-Exposure Prophylaxis Revenue by Type (2018-2029)
9.2 Asia Pre-Exposure Prophylaxis Market Size by Application
9.2.1 Asia Pre-Exposure Prophylaxis Sales by Application (2018-2029)
9.2.2 Asia Pre-Exposure Prophylaxis Revenue by Application (2018-2029)
9.3 Asia Pre-Exposure Prophylaxis Sales by Region
9.3.1 Asia Pre-Exposure Prophylaxis Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Pre-Exposure Prophylaxis Revenue by Region (2018-2029)
9.3.3 Asia Pre-Exposure Prophylaxis Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Market Size by Type
10.1.1 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Market Size by Application
10.2.1 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Country
10.3.1 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Information
11.1.2 Gilead Sciences Overview
11.1.3 Gilead Sciences Pre-Exposure Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Gilead Sciences Pre-Exposure Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Gilead Sciences Recent Developments
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Information
11.2.2 Teva Pharmaceuticals Overview
11.2.3 Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Teva Pharmaceuticals Pre-Exposure Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Pharmaceuticals Recent Developments
11.3 Strides Pharma Science
11.3.1 Strides Pharma Science Company Information
11.3.2 Strides Pharma Science Overview
11.3.3 Strides Pharma Science Pre-Exposure Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Strides Pharma Science Pre-Exposure Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Strides Pharma Science Recent Developments
11.4 Lupin
11.4.1 Lupin Company Information
11.4.2 Lupin Overview
11.4.3 Lupin Pre-Exposure Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Lupin Pre-Exposure Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lupin Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Pre-Exposure Prophylaxis Industry Chain Analysis
12.2 Pre-Exposure Prophylaxis Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pre-Exposure Prophylaxis Production Mode & Process
12.4 Pre-Exposure Prophylaxis Sales and Marketing
12.4.1 Pre-Exposure Prophylaxis Sales Channels
12.4.2 Pre-Exposure Prophylaxis Distributors
12.5 Pre-Exposure Prophylaxis Customers
13 MARKET DYNAMICS
13.1 Pre-Exposure Prophylaxis Industry Trends
13.2 Pre-Exposure Prophylaxis Market Drivers
13.3 Pre-Exposure Prophylaxis Market Challenges
13.4 Pre-Exposure Prophylaxis Market Restraints
14 KEY FINDINGS IN THE GLOBAL PRE-EXPOSURE PROPHYLAXIS STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Pre-Exposure Prophylaxis Product Introduction
1.2 Market by Type
1.2.1 Global Pre-Exposure Prophylaxis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Truvada
1.2.3 Discovy
1.3 Market by Application
1.3.1 Global Pre-Exposure Prophylaxis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Adult
1.3.3 Adolescent
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Pre-Exposure Prophylaxis Sales Estimates and Forecasts 2018-2029
2.2 Global Pre-Exposure Prophylaxis Revenue by Region
2.2.1 Global Pre-Exposure Prophylaxis Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Pre-Exposure Prophylaxis Revenue by Region (2018-2023)
2.2.3 Global Pre-Exposure Prophylaxis Revenue by Region (2024-2029)
2.2.4 Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2018-2029)
2.3 Global Pre-Exposure Prophylaxis Sales Estimates and Forecasts 2018-2029
2.4 Global Pre-Exposure Prophylaxis Sales by Region
2.4.1 Global Pre-Exposure Prophylaxis Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Pre-Exposure Prophylaxis Sales by Region (2018-2023)
2.4.3 Global Pre-Exposure Prophylaxis Sales by Region (2024-2029)
2.4.4 Global Pre-Exposure Prophylaxis Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Pre-Exposure Prophylaxis Sales by Manufacturers
3.1.1 Global Pre-Exposure Prophylaxis Sales by Manufacturers (2018-2023)
3.1.2 Global Pre-Exposure Prophylaxis Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pre-Exposure Prophylaxis in 2022
3.2 Global Pre-Exposure Prophylaxis Revenue by Manufacturers
3.2.1 Global Pre-Exposure Prophylaxis Revenue by Manufacturers (2018-2023)
3.2.2 Global Pre-Exposure Prophylaxis Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Pre-Exposure Prophylaxis Revenue in 2022
3.3 Global Key Players of Pre-Exposure Prophylaxis, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Pre-Exposure Prophylaxis Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pre-Exposure Prophylaxis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pre-Exposure Prophylaxis, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pre-Exposure Prophylaxis, Product Offered and Application
3.8 Global Key Manufacturers of Pre-Exposure Prophylaxis, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Pre-Exposure Prophylaxis Sales by Type
4.1.1 Global Pre-Exposure Prophylaxis Historical Sales by Type (2018-2023)
4.1.2 Global Pre-Exposure Prophylaxis Forecasted Sales by Type (2024-2029)
4.1.3 Global Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2029)
4.2 Global Pre-Exposure Prophylaxis Revenue by Type
4.2.1 Global Pre-Exposure Prophylaxis Historical Revenue by Type (2018-2023)
4.2.2 Global Pre-Exposure Prophylaxis Forecasted Revenue by Type (2024-2029)
4.2.3 Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2018-2029)
4.3 Global Pre-Exposure Prophylaxis Price by Type
4.3.1 Global Pre-Exposure Prophylaxis Price by Type (2018-2023)
4.3.2 Global Pre-Exposure Prophylaxis Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Pre-Exposure Prophylaxis Sales by Application
5.1.1 Global Pre-Exposure Prophylaxis Historical Sales by Application (2018-2023)
5.1.2 Global Pre-Exposure Prophylaxis Forecasted Sales by Application (2024-2029)
5.1.3 Global Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2029)
5.2 Global Pre-Exposure Prophylaxis Revenue by Application
5.2.1 Global Pre-Exposure Prophylaxis Historical Revenue by Application (2018-2023)
5.2.2 Global Pre-Exposure Prophylaxis Forecasted Revenue by Application (2024-2029)
5.2.3 Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2018-2029)
5.3 Global Pre-Exposure Prophylaxis Price by Application
5.3.1 Global Pre-Exposure Prophylaxis Price by Application (2018-2023)
5.3.2 Global Pre-Exposure Prophylaxis Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Pre-Exposure Prophylaxis Market Size by Type
6.1.1 US & Canada Pre-Exposure Prophylaxis Sales by Type (2018-2029)
6.1.2 US & Canada Pre-Exposure Prophylaxis Revenue by Type (2018-2029)
6.2 US & Canada Pre-Exposure Prophylaxis Market Size by Application
6.2.1 US & Canada Pre-Exposure Prophylaxis Sales by Application (2018-2029)
6.2.2 US & Canada Pre-Exposure Prophylaxis Revenue by Application (2018-2029)
6.3 US & Canada Pre-Exposure Prophylaxis Market Size by Country
6.3.1 US & Canada Pre-Exposure Prophylaxis Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Pre-Exposure Prophylaxis Sales by Country (2018-2029)
6.3.3 US & Canada Pre-Exposure Prophylaxis Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Pre-Exposure Prophylaxis Market Size by Type
7.1.1 Europe Pre-Exposure Prophylaxis Sales by Type (2018-2029)
7.1.2 Europe Pre-Exposure Prophylaxis Revenue by Type (2018-2029)
7.2 Europe Pre-Exposure Prophylaxis Market Size by Application
7.2.1 Europe Pre-Exposure Prophylaxis Sales by Application (2018-2029)
7.2.2 Europe Pre-Exposure Prophylaxis Revenue by Application (2018-2029)
7.3 Europe Pre-Exposure Prophylaxis Market Size by Country
7.3.1 Europe Pre-Exposure Prophylaxis Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Pre-Exposure Prophylaxis Sales by Country (2018-2029)
7.3.3 Europe Pre-Exposure Prophylaxis Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Pre-Exposure Prophylaxis Market Size
8.1.1 China Pre-Exposure Prophylaxis Sales (2018-2029)
8.1.2 China Pre-Exposure Prophylaxis Revenue (2018-2029)
8.2 China Pre-Exposure Prophylaxis Market Size by Application
8.2.1 China Pre-Exposure Prophylaxis Sales by Application (2018-2029)
8.2.2 China Pre-Exposure Prophylaxis Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Pre-Exposure Prophylaxis Market Size by Type
9.1.1 Asia Pre-Exposure Prophylaxis Sales by Type (2018-2029)
9.1.2 Asia Pre-Exposure Prophylaxis Revenue by Type (2018-2029)
9.2 Asia Pre-Exposure Prophylaxis Market Size by Application
9.2.1 Asia Pre-Exposure Prophylaxis Sales by Application (2018-2029)
9.2.2 Asia Pre-Exposure Prophylaxis Revenue by Application (2018-2029)
9.3 Asia Pre-Exposure Prophylaxis Sales by Region
9.3.1 Asia Pre-Exposure Prophylaxis Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Pre-Exposure Prophylaxis Revenue by Region (2018-2029)
9.3.3 Asia Pre-Exposure Prophylaxis Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Market Size by Type
10.1.1 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Market Size by Application
10.2.1 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Country
10.3.1 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Information
11.1.2 Gilead Sciences Overview
11.1.3 Gilead Sciences Pre-Exposure Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Gilead Sciences Pre-Exposure Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Gilead Sciences Recent Developments
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Information
11.2.2 Teva Pharmaceuticals Overview
11.2.3 Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Teva Pharmaceuticals Pre-Exposure Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Pharmaceuticals Recent Developments
11.3 Strides Pharma Science
11.3.1 Strides Pharma Science Company Information
11.3.2 Strides Pharma Science Overview
11.3.3 Strides Pharma Science Pre-Exposure Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Strides Pharma Science Pre-Exposure Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Strides Pharma Science Recent Developments
11.4 Lupin
11.4.1 Lupin Company Information
11.4.2 Lupin Overview
11.4.3 Lupin Pre-Exposure Prophylaxis Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Lupin Pre-Exposure Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lupin Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Pre-Exposure Prophylaxis Industry Chain Analysis
12.2 Pre-Exposure Prophylaxis Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pre-Exposure Prophylaxis Production Mode & Process
12.4 Pre-Exposure Prophylaxis Sales and Marketing
12.4.1 Pre-Exposure Prophylaxis Sales Channels
12.4.2 Pre-Exposure Prophylaxis Distributors
12.5 Pre-Exposure Prophylaxis Customers
13 MARKET DYNAMICS
13.1 Pre-Exposure Prophylaxis Industry Trends
13.2 Pre-Exposure Prophylaxis Market Drivers
13.3 Pre-Exposure Prophylaxis Market Challenges
13.4 Pre-Exposure Prophylaxis Market Restraints
14 KEY FINDINGS IN THE GLOBAL PRE-EXPOSURE PROPHYLAXIS STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Pre-Exposure Prophylaxis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Truvada
Table 3. Major Manufacturers of Discovy
Table 4. Global Pre-Exposure Prophylaxis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Pre-Exposure Prophylaxis Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Pre-Exposure Prophylaxis Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Pre-Exposure Prophylaxis Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2018-2023)
Table 9. Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2024-2029)
Table 10. Global Pre-Exposure Prophylaxis Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Pre-Exposure Prophylaxis Sales by Region (2018-2023) & (K Units)
Table 12. Global Pre-Exposure Prophylaxis Sales by Region (2024-2029) & (K Units)
Table 13. Global Pre-Exposure Prophylaxis Sales Market Share by Region (2018-2023)
Table 14. Global Pre-Exposure Prophylaxis Sales Market Share by Region (2024-2029)
Table 15. Global Pre-Exposure Prophylaxis Sales by Manufacturers (2018-2023) & (K Units)
Table 16. Global Pre-Exposure Prophylaxis Sales Share by Manufacturers (2018-2023)
Table 17. Global Pre-Exposure Prophylaxis Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Pre-Exposure Prophylaxis Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Pre-Exposure Prophylaxis, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Pre-Exposure Prophylaxis Price by Manufacturers 2018-2023 (US$/Unit)
Table 21. Global Pre-Exposure Prophylaxis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Pre-Exposure Prophylaxis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Exposure Prophylaxis as of 2022)
Table 23. Global Key Manufacturers of Pre-Exposure Prophylaxis, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Pre-Exposure Prophylaxis, Product Offered and Application
Table 25. Global Key Manufacturers of Pre-Exposure Prophylaxis, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 28. Global Pre-Exposure Prophylaxis Sales by Type (2024-2029) & (K Units)
Table 29. Global Pre-Exposure Prophylaxis Sales Share by Type (2018-2023)
Table 30. Global Pre-Exposure Prophylaxis Sales Share by Type (2024-2029)
Table 31. Global Pre-Exposure Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Pre-Exposure Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Pre-Exposure Prophylaxis Revenue Share by Type (2018-2023)
Table 34. Global Pre-Exposure Prophylaxis Revenue Share by Type (2024-2029)
Table 35. Pre-Exposure Prophylaxis Price by Type (2018-2023) & (US$/Unit)
Table 36. Global Pre-Exposure Prophylaxis Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 38. Global Pre-Exposure Prophylaxis Sales by Application (2024-2029) & (K Units)
Table 39. Global Pre-Exposure Prophylaxis Sales Share by Application (2018-2023)
Table 40. Global Pre-Exposure Prophylaxis Sales Share by Application (2024-2029)
Table 41. Global Pre-Exposure Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Pre-Exposure Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Pre-Exposure Prophylaxis Revenue Share by Application (2018-2023)
Table 44. Global Pre-Exposure Prophylaxis Revenue Share by Application (2024-2029)
Table 45. Pre-Exposure Prophylaxis Price by Application (2018-2023) & (US$/Unit)
Table 46. Global Pre-Exposure Prophylaxis Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 48. US & Canada Pre-Exposure Prophylaxis Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Pre-Exposure Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Pre-Exposure Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 52. US & Canada Pre-Exposure Prophylaxis Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Pre-Exposure Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Pre-Exposure Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Pre-Exposure Prophylaxis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Pre-Exposure Prophylaxis Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Pre-Exposure Prophylaxis Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Pre-Exposure Prophylaxis Sales by Country (2018-2023) & (K Units)
Table 59. US & Canada Pre-Exposure Prophylaxis Sales by Country (2024-2029) & (K Units)
Table 60. Europe Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 61. Europe Pre-Exposure Prophylaxis Sales by Type (2024-2029) & (K Units)
Table 62. Europe Pre-Exposure Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Pre-Exposure Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 65. Europe Pre-Exposure Prophylaxis Sales by Application (2024-2029) & (K Units)
Table 66. Europe Pre-Exposure Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Pre-Exposure Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Pre-Exposure Prophylaxis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Pre-Exposure Prophylaxis Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Pre-Exposure Prophylaxis Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Pre-Exposure Prophylaxis Sales by Country (2018-2023) & (K Units)
Table 72. Europe Pre-Exposure Prophylaxis Sales by Country (2024-2029) & (K Units)
Table 73. China Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 74. China Pre-Exposure Prophylaxis Sales by Type (2024-2029) & (K Units)
Table 75. China Pre-Exposure Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Pre-Exposure Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 78. China Pre-Exposure Prophylaxis Sales by Application (2024-2029) & (K Units)
Table 79. China Pre-Exposure Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Pre-Exposure Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 82. Asia Pre-Exposure Prophylaxis Sales by Type (2024-2029) & (K Units)
Table 83. Asia Pre-Exposure Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Pre-Exposure Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 86. Asia Pre-Exposure Prophylaxis Sales by Application (2024-2029) & (K Units)
Table 87. Asia Pre-Exposure Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Pre-Exposure Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Pre-Exposure Prophylaxis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Pre-Exposure Prophylaxis Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Pre-Exposure Prophylaxis Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Pre-Exposure Prophylaxis Sales by Region (2018-2023) & (K Units)
Table 93. Asia Pre-Exposure Prophylaxis Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 95. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Country (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Country (2024-2029) & (K Units)
Table 107. Gilead Sciences Company Information
Table 108. Gilead Sciences Description and Major Businesses
Table 109. Gilead Sciences Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Gilead Sciences Pre-Exposure Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Gilead Sciences Recent Developments
Table 112. Teva Pharmaceuticals Company Information
Table 113. Teva Pharmaceuticals Description and Major Businesses
Table 114. Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Teva Pharmaceuticals Pre-Exposure Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Teva Pharmaceuticals Recent Developments
Table 117. Strides Pharma Science Company Information
Table 118. Strides Pharma Science Description and Major Businesses
Table 119. Strides Pharma Science Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Strides Pharma Science Pre-Exposure Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Strides Pharma Science Recent Developments
Table 122. Lupin Company Information
Table 123. Lupin Description and Major Businesses
Table 124. Lupin Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Lupin Pre-Exposure Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Lupin Recent Developments
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Pre-Exposure Prophylaxis Distributors List
Table 130. Pre-Exposure Prophylaxis Customers List
Table 131. Pre-Exposure Prophylaxis Market Trends
Table 132. Pre-Exposure Prophylaxis Market Drivers
Table 133. Pre-Exposure Prophylaxis Market Challenges
Table 134. Pre-Exposure Prophylaxis Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 1. Global Pre-Exposure Prophylaxis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Truvada
Table 3. Major Manufacturers of Discovy
Table 4. Global Pre-Exposure Prophylaxis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Pre-Exposure Prophylaxis Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Pre-Exposure Prophylaxis Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Pre-Exposure Prophylaxis Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2018-2023)
Table 9. Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2024-2029)
Table 10. Global Pre-Exposure Prophylaxis Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Pre-Exposure Prophylaxis Sales by Region (2018-2023) & (K Units)
Table 12. Global Pre-Exposure Prophylaxis Sales by Region (2024-2029) & (K Units)
Table 13. Global Pre-Exposure Prophylaxis Sales Market Share by Region (2018-2023)
Table 14. Global Pre-Exposure Prophylaxis Sales Market Share by Region (2024-2029)
Table 15. Global Pre-Exposure Prophylaxis Sales by Manufacturers (2018-2023) & (K Units)
Table 16. Global Pre-Exposure Prophylaxis Sales Share by Manufacturers (2018-2023)
Table 17. Global Pre-Exposure Prophylaxis Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Pre-Exposure Prophylaxis Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Pre-Exposure Prophylaxis, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Pre-Exposure Prophylaxis Price by Manufacturers 2018-2023 (US$/Unit)
Table 21. Global Pre-Exposure Prophylaxis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Pre-Exposure Prophylaxis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Exposure Prophylaxis as of 2022)
Table 23. Global Key Manufacturers of Pre-Exposure Prophylaxis, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Pre-Exposure Prophylaxis, Product Offered and Application
Table 25. Global Key Manufacturers of Pre-Exposure Prophylaxis, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 28. Global Pre-Exposure Prophylaxis Sales by Type (2024-2029) & (K Units)
Table 29. Global Pre-Exposure Prophylaxis Sales Share by Type (2018-2023)
Table 30. Global Pre-Exposure Prophylaxis Sales Share by Type (2024-2029)
Table 31. Global Pre-Exposure Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Pre-Exposure Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Pre-Exposure Prophylaxis Revenue Share by Type (2018-2023)
Table 34. Global Pre-Exposure Prophylaxis Revenue Share by Type (2024-2029)
Table 35. Pre-Exposure Prophylaxis Price by Type (2018-2023) & (US$/Unit)
Table 36. Global Pre-Exposure Prophylaxis Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 38. Global Pre-Exposure Prophylaxis Sales by Application (2024-2029) & (K Units)
Table 39. Global Pre-Exposure Prophylaxis Sales Share by Application (2018-2023)
Table 40. Global Pre-Exposure Prophylaxis Sales Share by Application (2024-2029)
Table 41. Global Pre-Exposure Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Pre-Exposure Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Pre-Exposure Prophylaxis Revenue Share by Application (2018-2023)
Table 44. Global Pre-Exposure Prophylaxis Revenue Share by Application (2024-2029)
Table 45. Pre-Exposure Prophylaxis Price by Application (2018-2023) & (US$/Unit)
Table 46. Global Pre-Exposure Prophylaxis Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 48. US & Canada Pre-Exposure Prophylaxis Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Pre-Exposure Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Pre-Exposure Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 52. US & Canada Pre-Exposure Prophylaxis Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Pre-Exposure Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Pre-Exposure Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Pre-Exposure Prophylaxis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Pre-Exposure Prophylaxis Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Pre-Exposure Prophylaxis Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Pre-Exposure Prophylaxis Sales by Country (2018-2023) & (K Units)
Table 59. US & Canada Pre-Exposure Prophylaxis Sales by Country (2024-2029) & (K Units)
Table 60. Europe Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 61. Europe Pre-Exposure Prophylaxis Sales by Type (2024-2029) & (K Units)
Table 62. Europe Pre-Exposure Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Pre-Exposure Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 65. Europe Pre-Exposure Prophylaxis Sales by Application (2024-2029) & (K Units)
Table 66. Europe Pre-Exposure Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Pre-Exposure Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Pre-Exposure Prophylaxis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Pre-Exposure Prophylaxis Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Pre-Exposure Prophylaxis Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Pre-Exposure Prophylaxis Sales by Country (2018-2023) & (K Units)
Table 72. Europe Pre-Exposure Prophylaxis Sales by Country (2024-2029) & (K Units)
Table 73. China Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 74. China Pre-Exposure Prophylaxis Sales by Type (2024-2029) & (K Units)
Table 75. China Pre-Exposure Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Pre-Exposure Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 78. China Pre-Exposure Prophylaxis Sales by Application (2024-2029) & (K Units)
Table 79. China Pre-Exposure Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Pre-Exposure Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 82. Asia Pre-Exposure Prophylaxis Sales by Type (2024-2029) & (K Units)
Table 83. Asia Pre-Exposure Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Pre-Exposure Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 86. Asia Pre-Exposure Prophylaxis Sales by Application (2024-2029) & (K Units)
Table 87. Asia Pre-Exposure Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Pre-Exposure Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Pre-Exposure Prophylaxis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Pre-Exposure Prophylaxis Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Pre-Exposure Prophylaxis Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Pre-Exposure Prophylaxis Sales by Region (2018-2023) & (K Units)
Table 93. Asia Pre-Exposure Prophylaxis Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 95. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Country (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales by Country (2024-2029) & (K Units)
Table 107. Gilead Sciences Company Information
Table 108. Gilead Sciences Description and Major Businesses
Table 109. Gilead Sciences Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Gilead Sciences Pre-Exposure Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Gilead Sciences Recent Developments
Table 112. Teva Pharmaceuticals Company Information
Table 113. Teva Pharmaceuticals Description and Major Businesses
Table 114. Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Teva Pharmaceuticals Pre-Exposure Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Teva Pharmaceuticals Recent Developments
Table 117. Strides Pharma Science Company Information
Table 118. Strides Pharma Science Description and Major Businesses
Table 119. Strides Pharma Science Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Strides Pharma Science Pre-Exposure Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Strides Pharma Science Recent Developments
Table 122. Lupin Company Information
Table 123. Lupin Description and Major Businesses
Table 124. Lupin Pre-Exposure Prophylaxis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Lupin Pre-Exposure Prophylaxis Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Lupin Recent Developments
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Pre-Exposure Prophylaxis Distributors List
Table 130. Pre-Exposure Prophylaxis Customers List
Table 131. Pre-Exposure Prophylaxis Market Trends
Table 132. Pre-Exposure Prophylaxis Market Drivers
Table 133. Pre-Exposure Prophylaxis Market Challenges
Table 134. Pre-Exposure Prophylaxis Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Pre-Exposure Prophylaxis Product Picture
Figure 2. Global Pre-Exposure Prophylaxis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Pre-Exposure Prophylaxis Market Share by Type in 2022 & 2029
Figure 4. Truvada Product Picture
Figure 5. Discovy Product Picture
Figure 6. Global Pre-Exposure Prophylaxis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Pre-Exposure Prophylaxis Market Share by Application in 2022 & 2029
Figure 8. Adult
Figure 9. Adolescent
Figure 10. Pre-Exposure Prophylaxis Report Years Considered
Figure 11. Global Pre-Exposure Prophylaxis Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Pre-Exposure Prophylaxis Revenue 2018-2029 (US$ Million)
Figure 13. Global Pre-Exposure Prophylaxis Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2018-2029)
Figure 15. Global Pre-Exposure Prophylaxis Sales 2018-2029 ((K Units)
Figure 16. Global Pre-Exposure Prophylaxis Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Pre-Exposure Prophylaxis Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Pre-Exposure Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Pre-Exposure Prophylaxis Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Pre-Exposure Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Pre-Exposure Prophylaxis Sales YoY (2018-2029) & (K Units)
Figure 22. China Pre-Exposure Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Pre-Exposure Prophylaxis Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Pre-Exposure Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Pre-Exposure Prophylaxis Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Pre-Exposure Prophylaxis in the World: Market Share by Pre-Exposure Prophylaxis Revenue in 2022
Figure 29. Global Pre-Exposure Prophylaxis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2029)
Figure 31. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2018-2029)
Figure 32. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2029)
Figure 33. Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Pre-Exposure Prophylaxis Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Pre-Exposure Prophylaxis Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Pre-Exposure Prophylaxis Revenue Share by Country (2018-2029)
Figure 39. US & Canada Pre-Exposure Prophylaxis Sales Share by Country (2018-2029)
Figure 40. U.S. Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2029)
Figure 43. Europe Pre-Exposure Prophylaxis Revenue Market Share by Type (2018-2029)
Figure 44. Europe Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2029)
Figure 45. Europe Pre-Exposure Prophylaxis Revenue Market Share by Application (2018-2029)
Figure 46. Europe Pre-Exposure Prophylaxis Revenue Share by Country (2018-2029)
Figure 47. Europe Pre-Exposure Prophylaxis Sales Share by Country (2018-2029)
Figure 48. Germany Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 49. France Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 53. China Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2029)
Figure 54. China Pre-Exposure Prophylaxis Revenue Market Share by Type (2018-2029)
Figure 55. China Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2029)
Figure 56. China Pre-Exposure Prophylaxis Revenue Market Share by Application (2018-2029)
Figure 57. Asia Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2029)
Figure 58. Asia Pre-Exposure Prophylaxis Revenue Market Share by Type (2018-2029)
Figure 59. Asia Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2029)
Figure 60. Asia Pre-Exposure Prophylaxis Revenue Market Share by Application (2018-2029)
Figure 61. Asia Pre-Exposure Prophylaxis Revenue Share by Region (2018-2029)
Figure 62. Asia Pre-Exposure Prophylaxis Sales Share by Region (2018-2029)
Figure 63. Japan Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 67. India Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales Share by Country (2018-2029)
Figure 74. Brazil Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 79. Pre-Exposure Prophylaxis Value Chain
Figure 80. Pre-Exposure Prophylaxis Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
Figure 1. Pre-Exposure Prophylaxis Product Picture
Figure 2. Global Pre-Exposure Prophylaxis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Pre-Exposure Prophylaxis Market Share by Type in 2022 & 2029
Figure 4. Truvada Product Picture
Figure 5. Discovy Product Picture
Figure 6. Global Pre-Exposure Prophylaxis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Pre-Exposure Prophylaxis Market Share by Application in 2022 & 2029
Figure 8. Adult
Figure 9. Adolescent
Figure 10. Pre-Exposure Prophylaxis Report Years Considered
Figure 11. Global Pre-Exposure Prophylaxis Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Pre-Exposure Prophylaxis Revenue 2018-2029 (US$ Million)
Figure 13. Global Pre-Exposure Prophylaxis Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2018-2029)
Figure 15. Global Pre-Exposure Prophylaxis Sales 2018-2029 ((K Units)
Figure 16. Global Pre-Exposure Prophylaxis Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Pre-Exposure Prophylaxis Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Pre-Exposure Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Pre-Exposure Prophylaxis Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Pre-Exposure Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Pre-Exposure Prophylaxis Sales YoY (2018-2029) & (K Units)
Figure 22. China Pre-Exposure Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Pre-Exposure Prophylaxis Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Pre-Exposure Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Pre-Exposure Prophylaxis Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Pre-Exposure Prophylaxis in the World: Market Share by Pre-Exposure Prophylaxis Revenue in 2022
Figure 29. Global Pre-Exposure Prophylaxis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2029)
Figure 31. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2018-2029)
Figure 32. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2029)
Figure 33. Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Pre-Exposure Prophylaxis Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Pre-Exposure Prophylaxis Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Pre-Exposure Prophylaxis Revenue Share by Country (2018-2029)
Figure 39. US & Canada Pre-Exposure Prophylaxis Sales Share by Country (2018-2029)
Figure 40. U.S. Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2029)
Figure 43. Europe Pre-Exposure Prophylaxis Revenue Market Share by Type (2018-2029)
Figure 44. Europe Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2029)
Figure 45. Europe Pre-Exposure Prophylaxis Revenue Market Share by Application (2018-2029)
Figure 46. Europe Pre-Exposure Prophylaxis Revenue Share by Country (2018-2029)
Figure 47. Europe Pre-Exposure Prophylaxis Sales Share by Country (2018-2029)
Figure 48. Germany Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 49. France Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 53. China Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2029)
Figure 54. China Pre-Exposure Prophylaxis Revenue Market Share by Type (2018-2029)
Figure 55. China Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2029)
Figure 56. China Pre-Exposure Prophylaxis Revenue Market Share by Application (2018-2029)
Figure 57. Asia Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2029)
Figure 58. Asia Pre-Exposure Prophylaxis Revenue Market Share by Type (2018-2029)
Figure 59. Asia Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2029)
Figure 60. Asia Pre-Exposure Prophylaxis Revenue Market Share by Application (2018-2029)
Figure 61. Asia Pre-Exposure Prophylaxis Revenue Share by Region (2018-2029)
Figure 62. Asia Pre-Exposure Prophylaxis Sales Share by Region (2018-2029)
Figure 63. Japan Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 67. India Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Pre-Exposure Prophylaxis Sales Share by Country (2018-2029)
Figure 74. Brazil Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Pre-Exposure Prophylaxis Revenue (2018-2029) & (US$ Million)
Figure 79. Pre-Exposure Prophylaxis Value Chain
Figure 80. Pre-Exposure Prophylaxis Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
